PET/CT in Breast Cancer / Rakesh Kumar, Kanhaiyalal Agrawal, Narainder K. Gupta, editors.
Kumar, Rakesh.; Agrawal, Kanhaiyalal.; Gupta, Narainder K.
2023
RC280.B8
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title PET/CT in Breast Cancer / Rakesh Kumar, Kanhaiyalal Agrawal, Narainder K. Gupta, editors.
ISBN 9783031295904
3031295900
3031295897
9783031295898
DOI https://doi.org/10.1007/978-3-031-29590-4
Publication Details Cham : Springer International Publishing AG, 2023.
Language English
Description 1 online resource (xiii, 100 pages) : illustrations (some color).
Item Number 10.1007/978-3-031-29590-4 doi
Call Number RC280.B8
Dewey Decimal Classification 616.99/4490757
Summary The aim of this book is to provide crisp information related to pathology, management and radiological/molecular imaging in breast carcinoma, along with detailed information on FDG PET-CT in breast cancer, normal variants, artefacts, pitfalls with atlas illustrations. The book is unique in providing quick reference to practice of PET/CT in breast cancer. The initial few chapters are related to the pathology and management of breast carcinoma to help understand the pathophysiology of breast cancer before going to the imaging. The chapter on imaging in breast cancer highlights the role of different imaging modalities for different indications to the reader. The last four chapters describe in detail the role, normal variants, artefacts and pitfalls of FDG PET/CT along with recent molecular imaging advances in breast cancer. Written by Pathology, Oncology, Radiology and Nuclear Medicine experts from different countries with enormous experience in breast cancer practice, the book addresses nuclear medicine physicians and radiologists, but it may be of interest to a wider medical community, including oncologists and radiotherapists.
Bibliography, etc. Note References -- 5: FDG PET/CT in Breast Cancer -- 5.1 Introduction -- 5.2 Primary Diagnosis and Staging -- 5.3 Response Assessment -- 5.4 Radiotherapy Planning -- 5.5 Normal Variants and Artifacts -- 5.5.1 Benign Variants -- 5.5.2 Effects of Inflammation and Therapy -- 5.6 Artifacts -- 5.7 Advantages -- 5.8 Limitations/Pitfalls -- 5.9 Sentinel Lymph Node -- 5.10 Positron Emission Mammography -- References -- 6: FDG-PET/CT in Breast Cancer: Normal Variants, Artifacts, and Pitfalls -- 6.1 Introduction -- 6.1.1 Normal Variants -- 6.1.1.1 Physiological Breast Changes
Access Note Access limited to authorized users.
Source of Description Description based upon print version of record.
Added Author Kumar, Rakesh.
Agrawal, Kanhaiyalal.
Gupta, Narainder K.
Series Clinicians' guides to radionuclide hybrid imaging. PET/CT.
Available in Other Form PET/CT in Breast Cancer
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Intro
Foreword
Preface
Acknowledgements
Contents
1: Clinical Background of Breast Cancer
1.1 Epidemiology and Risk Factors
1.1.1 Clinical Presentation
1.1.2 Diagnosis
1.1.3 Staging and Classification
1.1.4 Outcomes
References
2: Pathology of Breast Cancer
2.1 Invasive Breast Carcinoma of No Special Type (IC-NST)
2.2 Invasive Lobular Carcinoma
2.3 Invasive Tubular Carcinoma
2.4 Invasive Mucinous Carcinoma
2.5 Invasive Micropapillary Carcinoma
2.6 Invasive Metaplastic Carcinoma
2.7 Invasive Carcinoma with Medullary Features

2.8 Adenoid Cystic Carcinoma (AdCC)
2.9 Prognostic and Predictive Factors
References
3: Management of Breast Cancer
3.1 Local Management of Early Breast Cancer
3.1.1 Pure Non-Invasive Carcinoma: Ductal Carcinoma In Situ
3.1.2 Lobular Carcinoma In Situ (LCIS) or Lobular Neoplasia
3.1.3 Early-stage Invasive Breast Cancer
3.1.4 Locally Advanced Breast Cancer
3.1.5 T4 and Inflammatory Breast Cancer
3.2 Breast Cancer Subtypes and Systemic Therapy
3.3 Patient Follow-Up
3.4 Male Breast Cancer
3.5 Stage IV or Metastatic Breast Cancer

3.5.1 Endocrine Therapy for Metastatic Disease
3.5.2 HER2-Targeted Therapy for Metastatic Breast Cancer
3.5.3 Triple-Negative Disease
3.5.4 BRCA Mutant Breast Cancer
3.6 Assessing Treatment Response in Metastatic Breast Cancer
References
4: Radiological Imaging of Breast Cancer
4.1 Introduction
4.2 Screening and Diagnosis
4.2.1 Mammography
4.2.2 USG
4.2.3 MRI
4.2.4 Thermography
4.3 Staging of Breast Cancer
4.4 Response Assessment and Surveillance
4.5 Radiotherapy Planning
4.6 Artifacts on Imaging
4.7 Essential to Remember

6.1.1.2 Iatrogenic Changes
6.1.2 Benign Breast Tumors
6.1.3 Artifacts and Pitfalls
6.1.3.1 Elsewhere in the Body in Breast Cancer Assessment
6.1.3.2 Technical Artifacts
6.1.4 False Negatives
References
7: Recent Advances in Molecular Imaging of Breast Cancer
7.1 Novel Tracers Used in Management of Breast Carcinoma
7.1.1 Estrogen Receptor Imaging
7.1.2 HER2 Targeted Imaging
7.1.3 Proliferation Marker
7.1.4 Hypoxia Imaging
7.1.5 Angiogenesis Imaging
7.1.6 Tumor Neovascularization Imaging
7.1.7 Fibroblast Activating Protein Targeted Imaging

Browse Subjects

Show more subjects...

Statistics

from
to
Export